Great to hear you are invested as well, biotech_researcher. I also believe GE will take over eventually and use their clout to have the device installed in clinics around the world. Being the second largest maker of diagnostic imaging devices, GE would want to move the strategic partnership to the next level and add this machine to their portfolio instead of see it taken by a competitor IMO.
GE Healthcare, a business unit of General Electric Company, provides transformational medical technologies and services, as well as consulting services. With headquarters in Buckinghamshire, UK, it carries out the design, development, manufacture and distribution of medical systems in the field of medical imaging and information technologies, medical diagnostics, patient monitoring, drug discovery, and biopharmaceutical manufacturing technologies.
GE Healthcare also provides services, such as performance improvement and solutions services, computerised data management, and remote diagnostic and repair services of medical equipment manufactured by the company and others.
GE Healthcare’s products are used in cardiology; neurology; emergency medicine; oncology; woman’s health; ear, nose and throat (ENT); musculoskeletal; emergency care; radiology; paediatrics; urology and in the obstetrics/gynaecology areas. The company recorded revenue of $18.1 billion during the fiscal year ended December 2011.
The company’s business is divided chiefly into five segments: surgery, healthcare systems, life sciences, medical diagnostics and healthcare IT.
The medical diagnostics segment is engaged in the research, manufacture and marketing of innovative imaging agents, which are used in medical scanning procedures to highlight organs, tissues and functions inside the human body. These agents help physicians in the early detection, diagnosis and management of diseases. The company’s diagnostic imaging products include ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), mammography, molecular imaging, nuclear medicine, positron emission tomography (PET), radiopharmacy, pre-clinical imaging, radiography and radiography, and fluoroscopy systems.
In August 2012, the company received CE marking for its Discovery IGS 730, interventional X-ray system. It has introduced the Optima NM/CT 640 – the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT system.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AI
